The Patent Finder

Eikon Therapeutics, Inc.

Also on record
Records under this name other than the patents Eikon Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 4 of 4 · Back to Eikon Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,062,026Fused pyrimidines and substituted quinazolines as inhibitors of p97
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,475,824Fused Pyrimidines as Inhibitors of P97 Complex
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,010,554Fused Pyrimidines as Inhibitors of P97 Complex
Formerly held
Lapsed on the fee record
Ended Jul 3, 2026 · Medium confidence
Lapsed on the fee recordEnded Jul 3, 2026Medium confidence
US 9,868,722Monocyclic pyrimidine/pyridine compounds as inhibitors of P97 complex
Formerly held
Lapsed on the fee record
Ended Jan 16, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 16, 2026USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited